Repatriation Medical Authority – Notice of Investigation – Malignant Neoplasm of the Prostate – focussed

Overview

The Repatriation Medical Authority (the Authority) has announced an investigation under section 196G of the Veterans' Entitlements Act 1986 (the VEA) to explore the potential link between asbestos exposure and malignant neoplasm of the prostate, in line with Statements of Principles Instrument Nos. 53 and 54 of 2014. This investigation aims to address a gap in the understanding of how environmental factors, specifically asbestos exposure, may contribute to the development of prostate cancer among veterans. The Authority has invited submissions from various stakeholders, including individuals eligible for veterans' benefits, relevant organisations, and experts in the field, to provide comprehensive insights into this matter. Submissions are due by 18 June 2021 and can be made electronically through the RMA website or by email, with guidelines available online to assist contributors. This initiative underscores the commitment of the Authority to thoroughly examine and address issues pertinent to veterans' health.

Scope and Application

The Repatriation Medical Authority (the Authority) has issued a notice under section 196G of the Veterans' Entitlements Act 1986 (the VEA) to conduct an investigation regarding asbestos exposure as a potential factor in malignant neoplasm of the prostate. This investigation will be conducted in accordance with the provisions of Statements of Principles Instrument Nos. 53 and 54 of 2014, as amended. The Authority seeks submissions from eligible claimants, representatives of veterans and their families, relevant government commissions, and experts in fields pertinent to the investigation. Submissions can be made electronically via the RMA website, by email, or by post, and must be received by 18 June 2021. The Authority, directed by Professor Nicholas Saunders AO, Chairperson, will hold its first meeting on 7 July 2021 to discuss the investigation. The scope of the Act applies to individuals who are eligible to claim pensions under Part II or Part IV of the VEA, or compensation under the Military Rehabilitation and Compensation Act 2004, as well as to organisations representing veterans and other specified groups, and experts with relevant expertise. The investigation pertains to the geographic and jurisdictional reach of Australia, with no specified exclusions or exemptions outlined in this notice. The application of the Act may be further detailed or extended through subordinate instruments, which are not explicitly mentioned in this notice.

Key Provisions

The main operative sections of this legislation are sections 196G and 196B(7A) of the Veterans' Entitlements Act 1986 (VEA). Section 196G permits the Repatriation Medical Authority (the Authority) to carry out an investigation concerning asbestos exposure as a factor in malignant neoplasm of the prostate. This investigation is to be conducted within the context of Statements of Principles Instrument Nos. 53 and 54 of 2014, as amended, concerning malignant neoplasm of the prostate. The Authority has invited specific individuals and organisations to make written submissions regarding the investigation, including veterans and their representatives, relevant commissions, and experts in relevant fields. The obligations imposed by this Act are primarily on those invited to make submissions. Eligible individuals and organisations are required to submit their written submissions by 18 June 2021. Submissions must be made using the RMA website, emailed to the specified address, or posted to the RMA. The RMA Submission Guidelines are available for reference, and the RMA Secretariat can provide further assistance. The Authority's first meeting to discuss this investigation is scheduled for 7 July 2021. The legislation does not explicitly outline specific offences, penalties, or consequences for non-compliance with the submission requirements. However, the absence of submissions by the deadline may result in the invited individuals and organisations being unable to contribute to the investigation, potentially impacting their interests and the scope of the investigation. The Act emphasises the importance of timely and proper submissions to ensure a comprehensive investigation. The Notice of Investigation itself does not detail specific penalties for non-compliance with the submission process, but it underscores the importance of adhering to the timelines and submission guidelines provided by the Authority. Failure to meet these obligations might indirectly affect the investigation's thoroughness and the outcomes for the individuals and organisations involved.